Cover
Cover - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Apr. 24, 2024 | Jun. 30, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K/A | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2023 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity File Number | 001-37977 | ||
Entity Registrant Name | AVADEL PHARMACEUTICALS PLC | ||
Entity Central Index Key | 0001012477 | ||
Entity Tax Identification Number | 98-1341933 | ||
Entity Incorporation, State or Country Code | L2 | ||
Entity Address, Address Line One | 10 Earlsfort Terrace | ||
Entity Address, City or Town | Dublin 2 | ||
Entity Address, Country | IE | ||
Entity Address, Postal Zip Code | D02 T380 | ||
Country Region | 353 | ||
City Area Code | 1 | ||
Local Phone Number | 901-5201 | ||
Title of 12(b) Security | Ordinary Shares, nominal value $0.01 per share | ||
Trading Symbol | AVDL | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 1,459,121,731 | ||
Entity Common Stock, Shares Outstanding | 96,116,323 | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction [Flag] | false | ||
Auditor Name | Deloitte and Touche LLP | ||
Auditor Location | St. Louis, Missouri | ||
Auditor Firm ID | 34 |